For: |
Shen SG, Zhang D, Hu HT, Li JH, Wang Z, Ma QY. Effects of α-adrenoreceptor antagonists on apoptosis and proliferation of pancreatic cancer cells |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i15/2358.htm |
Number | Citing Articles |
1 |
Hong-bo Huan, Xu-dong Wen, Xue-jiao Chen, Lin Wu, Li-li Wu, Liang Zhang, Da-peng Yang, Xia Zhang, Ping Bie, Cheng Qian, Feng Xia. Sympathetic nervous system promotes hepatocarcinogenesis by modulating inflammation through activation of alpha1-adrenergic receptors of Kupffer cells. Brain, Behavior, and Immunity 2017; 59: 118 doi: 10.1016/j.bbi.2016.08.016
|
2 |
Yani Zhao, Yan Zhang, Yao Li, Min Yang, Jiani Yuan, Yu Cao, Lu Xu, Xuexinyu Ma, Sisong Lin, Junming An, Siwang Wang. Yohimbine hydrochloride inhibits benign prostatic hyperplasia by downregulating steroid 5α-reductase type 2. European Journal of Pharmacology 2021; 908: 174334 doi: 10.1016/j.ejphar.2021.174334
|
3 |
Heng-tong Hu, Qing-yong Ma, Dong Zhang, Su-gang Shen, Liang Han, Ya-dong Ma, Ruo-fei Li, Ke-ping Xie. HIF-1α links β-adrenoceptor agonists and pancreatic cancer cells under normoxic condition. Acta Pharmacologica Sinica 2010; 31(1): 102 doi: 10.1038/aps.2009.181
|
4 |
Jouhyun Jeon, Satra Nim, Joan Teyra, Alessandro Datti, Jeffrey L Wrana, Sachdev S Sidhu, Jason Moffat, Philip M Kim. A systematic approach to identify novel cancer drug targets using machine learning, inhibitor design and high-throughput screening. Genome Medicine 2014; 6(7) doi: 10.1186/s13073-014-0057-7
|
5 |
Marisa Coelho, Cátia Soares-Silva, Daniela Brandão, Franca Marino, Marco Cosentino, Laura Ribeiro. β-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives. Journal of Cancer Research and Clinical Oncology 2017; 143(2): 275 doi: 10.1007/s00432-016-2278-1
|
6 |
Weina Wang, Xin Guo, Huiwen Dan. <p>α2A-Adrenergic Receptor Inhibits the Progression of Cervical Cancer Through Blocking PI3K/AKT/mTOR Pathway</p>. OncoTargets and Therapy 2020; : 10535 doi: 10.2147/OTT.S264409
|
7 |
Han Yang, Michal Poznik, Shaojian Tang, Peng Xue, Lidong Du, Chenlu Liu, Xiaochuan Chen, Jason J. Chruma. Synthesis of Conformationally Liberated Yohimbine Analogues and Evaluation of Cytotoxic Activity. ACS Omega 2021; 6(29): 19291 doi: 10.1021/acsomega.1c02784
|
8 |
Mallory Batty, Rachel Pugh, Ilampirai Rathinam, Joshua Simmonds, Edwin Walker, Amanda Forbes, Shailendra Anoopkumar-Dukie, Catherine McDermott, Briohny Spencer, David Christie, Russ Chess-Williams. The Role of α1-Adrenoceptor Antagonists in the Treatment of Prostate and Other Cancers. International Journal of Molecular Sciences 2016; 17(8): 1339 doi: 10.3390/ijms17081339
|
9 |
Rajagopal Anitha, Rajakannu Subashini, Gomathi Kannayiram, Dasararaju Gayathri. Chronic Inflammatory-Modulating Potential of Cassia auriculata with Proinflammatory Cytokine IL-1beta and Its Anticancer Effect on Lung Cancer Cell Line. Anti-Cancer Agents in Medicinal Chemistry 2021; 21(3): 343 doi: 10.2174/1871520620666200811111114
|
10 |
Azar Ramezanpour, Kazem Karami, Mahshid Kharaziha, Mostafa Zakariazadeh, Janusz Lipkowski, Azar Shahpiri, Negar Azizi, Mansoor Namazian. A mononuclear PdII complex with Naphcon; crystal structure, experimental and computational studies of the interaction with DNA/BSA and evaluation of anticancer activity. Polyhedron 2021; 206: 115333 doi: 10.1016/j.poly.2021.115333
|
11 |
Jing Dong, Ji Che, Yuanyuan Wu, Yixu Deng, Xuliang Jiang, Zhiyong He, Jun Zhang. Dexmedetomidine promotes colorectal cancer progression via Piwil2 signaling. Cellular Oncology 2024; 47(4): 1459 doi: 10.1007/s13402-024-00944-8
|
12 |
Ada María Herrera-García, María Jesús Domínguez-Luis, María Arce-Franco, Estefanía Armas-González, Diego Álvarez de La Rosa, José David Machado, Martina K. Pec, Manuel Feria, Olga Barreiro, Francisco Sánchez-Madrid, Federico Díaz-González. Prevention of Neutrophil Extravasation by α2-Adrenoceptor–Mediated Endothelial Stabilization. The Journal of Immunology 2014; 193(6): 3023 doi: 10.4049/jimmunol.1400255
|
13 |
Jennifer L. Fisher, Elizabeth J. Wilk, Vishal H. Oza, Sam E. Gary, Timothy C. Howton, Victoria L. Flanary, Amanda D. Clark, Anita B. Hjelmeland, Brittany N. Lasseigne. Signature reversion of three disease‐associated gene signatures prioritizes cancer drug repurposing candidates. FEBS Open Bio 2024; 14(5): 803 doi: 10.1002/2211-5463.13796
|
14 |
Yang Liu, Xiaochen Yu, Junling Zhuang. Epinephrine Stimulates Cell Proliferation and Induces Chemoresistance in Myeloma Cells through the β-Adrenoreceptor in vitro. Acta Haematologica 2017; 138(2): 103 doi: 10.1159/000478517
|
15 |
Konstantinos N Tzirogiannis, Kalliopi T Kourentzi, Sofia Zyga, Vassiliki Papalimneou, Maria Tsironi, Agni D Grypioti, Ioannis Protopsaltis, Dimitrios Panidis, Georgios I Panoutsopoulos. Effect of 5-HT7receptor blockade on liver regeneration after 60-70% partial hepatectomy. BMC Gastroenterology 2014; 14(1) doi: 10.1186/s12876-014-0201-2
|
16 |
Perioperative Effects of Surgery, Anesthesia and Analgesics Associated with Cancer Progression: A Review . Journal of Cancer Research Updates 2018; 7(1): 1 doi: 10.6000/1929-2279.2018.07.01.1
|
17 |
Bina Raju, Salah O. Ibrahim. Pathophysiology of oral cancer in experimental animal models: a review with focus on the role of sympathetic nerves. Journal of Oral Pathology & Medicine 2011; 40(1): 1 doi: 10.1111/j.1600-0714.2010.00928.x
|
18 |
Mary F. McGuire. Pancreatic Cancer: Insights from Counterterrorism Theories. Decision Analysis 2014; 11(4): 265 doi: 10.1287/deca.2014.0301
|
19 |
Hannah P. Priyanka, Uday P. Pratap, Rahul S. Nair, Ramasamy Vasantharekha, Srinivasan ThyagaRajan. Estrogen-receptor status determines differential regulation of α1- and α2-adrenoceptor-mediated cell survival, angiogenesis, and intracellular signaling responses in breast cancer cell lines. Medical Oncology 2024; 41(5) doi: 10.1007/s12032-024-02322-8
|
20 |
Leejin Lim, Hyeonhwa Kim, Jihye Jeong, Sung Hee Han, Young-Bob Yu, Heesang Song. Yohimbine Inhibits PDGF-Induced Vascular Smooth Muscle Cell Proliferation and Migration via FOXO3a Factor. International Journal of Molecular Sciences 2024; 25(13): 6899 doi: 10.3390/ijms25136899
|
21 |
M Pérez-Sayáns, JM Somoza-Martín, F Barros-Angueira, P Gayoso-Diz, EM Otero-Rey, JM Gándra-Rey, A García-García. Activity of β2-adrenergic receptor in oral squamous cell carcinoma is mediated by overexpression of the ADRBK2 gene: a pilot study. Biotechnic & Histochemistry 2012; 87(3): 179 doi: 10.3109/10520295.2011.592151
|
22 |
Jude A. Oben, Trusha Patel, Angelina Mouralidarane, Ann Maj Samuelsson, Phillippa Matthews, Joaquim Pombo, Maelle Morgan, Chad Mckee, Junpei Soeda, Marco Novelli, Lucilla Poston, Paul Taylor. Maternal obesity programmes offspring development of non-alcoholic fatty pancreas disease. Biochemical and Biophysical Research Communications 2010; 394(1): 24 doi: 10.1016/j.bbrc.2010.02.057
|
23 |
Anik Banik, Sheikh Rashel Ahmed, Emran Hossain Sajib, Anamika Deb, Shiuly Sinha, Kazi Faizul Azim. Identification of potential inhibitory analogs of metastasis tumor antigens (MTAs) using bioactive compounds: revealing therapeutic option to prevent malignancy. Molecular Diversity 2022; 26(5): 2473 doi: 10.1007/s11030-021-10345-w
|
24 |
Hermann A.M. Mucke. Drug Repurposing Patent Applications October: December 2021. ASSAY and Drug Development Technologies 2022; 20(2): 95 doi: 10.1089/adt.2022.002
|
25 |
Chih-Wei Chiu, Cheng-Ying Hsieh, Chih-Hao Yang, Jie-Heng Tsai, Shih-Yi Huang, Joen-Rong Sheu. Yohimbine, an α2-Adrenoceptor Antagonist, Suppresses PDGF-BB-Stimulated Vascular Smooth Muscle Cell Proliferation by Downregulating the PLCγ1 Signaling Pathway. International Journal of Molecular Sciences 2022; 23(14): 8049 doi: 10.3390/ijms23148049
|
26 |
Adel M. Abuzenadah, Fatin Al-Sayes, Syed Sahajada Mahafujul Alam, Mehboob Hoque, Sajjad Karim, Ibtessam M.R. Hussain, Shams Tabrez, Arpita Roy. Identification of Potential Poly (ADP-Ribose) Polymerase-1 Inhibitors Derived from Rauwolfia serpentina: Possible Implication in Cancer Therapy. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/3787162
|
27 |
Andres Missair, Juan Pablo Cata, Gina Votta-Velis, Mark Johnson, Alain Borgeat, Mohammed Tiouririne, Vijay Gottumukkala, Donal Buggy, Ricardo Vallejo, Esther Benedetti de Marrero, Dan Sessler, Marc A Huntoon, Jose De Andres, Oscar De Leon Casasola. Impact of perioperative pain management on cancer recurrence: an ASRA/ESRA special article. Regional Anesthesia & Pain Medicine 2019; 44(1): 13 doi: 10.1136/rapm-2018-000001
|
28 |
Nasimudeen R. Jabir, Chelapram K. Firoz, Torki A. Zughaibi, Mohammed Abdullah Alsaadi, Adel M. Abuzenadah, Ahmed Ibrahim Al-Asmari, Ahdab Alsaieedi, Bakrudeen Ali Ahmed, Arun Kumar Ramu, Shams Tabrez. A literature perspective on the pharmacological applications of yohimbine. Annals of Medicine 2022; 54(1): 2849 doi: 10.1080/07853890.2022.2131330
|
29 |
Adel M. Abuzenadah, Fatin Al-Sayes, Syed Sahajada Mahafujul Alam, Mehboob Hoque, Sajjad Karim, Ibtessam M. R. Hussain, Shams Tabrez, Arpita Roy. Elucidating Antiangiogenic Potential of Rauwolfia serpentina: VEGFR-2 Targeting-Based Molecular Docking Study. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/6224666
|
30 |
Nasimudeen R. Jabir, Mohd Shahnawaz Khan, Nouf Omar Alafaleq, Huma Naz, Bakrudeen Ali Ahmed. Anticancer potential of yohimbine in drug-resistant oral cancer KB-ChR-8–5 cells. Molecular Biology Reports 2022; 49(10): 9565 doi: 10.1007/s11033-022-07847-7
|
31 |
Ting Fu, Xiaofeng Qin, Yining Ma, Xinyue Yuan, Siyun Wu, Xiyun Ye, Yongyan Dang. Yohimbine hydrochloride inhibits skin melanin synthesis by regulating wnt/β-catenin and p38/MAPK signal pathways. Journal of Dermatological Science 2022; 107(1): 17 doi: 10.1016/j.jdermsci.2022.06.005
|
32 |
Nasimudeen R. Jabir, Shams Tabrez, Nojood Altwaijry, Mohd Shahnawaz Khan, Arun Kumar Ramu, Bakrudeen Ali Ahmed. Estimating Anticancer Effects of Yohimbine in DMBA‐Induced Oral Carcinogenesis Hamster Model: Utilizing Biochemical and Immunohistochemical Techniques. Cell Biochemistry and Function 2024; 42(7) doi: 10.1002/cbf.4132
|